Education
About Us
Working with TipRanks
Follow Us
Acura Pharmaceuticals (ACUR)
OTHER OTC:ACUR
| Dec 21 | Dec 20 | Dec 19 | Dec 18 | Dec 17 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 1.56M | $ 3.57M | $ 2.66M | $ 410.00K | $ 2.97M |
| Gross Profit | $ 352.00K | $ 3.57M | $ 2.65M | $ 408.24K | $ 2.84M |
| Operating Income | $ -1.21M | $ -758.00K | $ -725.00K | $ -3.92M | $ -5.22M |
| EBITDA | $ -589.00K | $ -633.00K | $ -3.04M | $ -3.17M | $ -4.93M |
| Net Income | $ -879.00K | $ -1.21M | $ -3.77M | $ -3.84M | $ -5.68M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 65.00K | $ 413.00K | $ 862.00K | $ 91.00K | $ 2.22M |
| Total Assets | $ 860.00K | $ 1.74M | $ 2.56M | $ 2.15M | $ 4.60M |
| Total Debt | $ 200.00K | $ 6.27M | $ 6.00M | $ 4.22M | $ 2.69M |
| Net Debt | $ 135.00K | $ 5.86M | $ 5.14M | $ 4.13M | $ 474.00K |
| Total Liabilities | $ 682.00K | $ 7.63M | $ 7.30M | $ 5.77M | $ 4.63M |
| Stockholders' Equity | $ 178.00K | $ -5.89M | $ -4.74M | $ -3.62M | $ -27.00K |
| Cash Flow | |||||
| Free Cash Flow | $ -742.00K | $ -719.00K | $ -618.00K | $ -3.91M | $ -4.51M |
| Operating Cash Flow | $ -742.00K | $ -719.00K | $ -618.00K | $ -3.91M | $ -4.51M |
| Investing Cash Flow | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 309.00K |
| Financing Cash Flow | $ 394.00K | $ 270.00K | $ 1.39M | $ 1.78M | $ 1.24M |
Acura Pharmaceuticals Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.